The In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746 is specific to the European Union. Its impact can however extend beyond EU borders. For example, regulatory requirements in major markets such as the EU can influence developments and changes in standards in other regions.  The regulation can also affect players in the supply chain who themselves operate outside the EU but supply to organisations who do wish to market into the EU zone.